Search

everythinglearnresearchcommunity

for

Search:↓

Phytochemicals may offer safer alternatives to synthetic drugs for prostate cancer treatment.

AH-001 could be a safer and more effective treatment for hair loss.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Androgen receptors help prostate cancer cells grow and resist drugs.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

Blocking CRF-R1 can reduce alcohol intake in stressed mice.

Cadd4 effectively reduces cholesterol levels without side effects.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

5alpha-reductase inhibitors help treat hair loss and prostate issues but may cause sexual side effects.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

Regulatory challenges make developing combination therapies in urology difficult and costly.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

Removing the ROBO4 gene in mice reduces skin inflammation and hair loss by affecting certain inflammation pathways and gene expression.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

AHR ligands could treat inflammatory skin diseases.